Moderna said it has enough data for a first interim analysis of the late-stage trial of its experimental Covid-19 vaccine, which should help determine the vaccine's efficacy
from Latest News https://ift.tt/3kn5r9A
Wednesday, 11 November 2020
Have enough data for first interim analysis of Covid-19 vaccine: Moderna
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment